PURPOSE: To identify the neural correlates of cognitive improvement in mild Alzheimer's disease (AD) subjects following 12 weeks of donepezil treatment. MATERIALS AND METHODS: Resting-state functional connectivity magnetic resonance imaging (R-fMRI) was used to measure the hippocampal functional connectivity (HFC) in 14 mild AD and 18 age-matched normal (CN) subjects. AD subjects were scanned at baseline and after donepezil treatment. CN subjects were scanned only at baseline as a reference to identify regions correlated or anticorrelated to the hippocampus. Before each scan, participants underwent cognitive, behavioral, and functional assessments. RESULTS: After donepezil treatment, neural correlates of cognitive improvement measured by Mini-Mental State Examination scores were identified in the left parahippocampus, dorsolateral prefrontal cortex (DLPFC), and inferior frontal gyrus. Improvement in AD Assessment Scale-cognitive subscale scores correlated with the HFC changes in the left DLPFC and middle frontal gyrus. Stronger recovery in the network connectivity was associated with cognitive improvement. CONCLUSION: R-fMRI may provide novel insights into the brain's responses to AD treatment in clinical pharmacological trials, and also may predict clinical response.
PURPOSE: To identify the neural correlates of cognitive improvement in mild Alzheimer's disease (AD) subjects following 12 weeks of donepezil treatment. MATERIALS AND METHODS: Resting-state functional connectivity magnetic resonance imaging (R-fMRI) was used to measure the hippocampal functional connectivity (HFC) in 14 mild AD and 18 age-matched normal (CN) subjects. AD subjects were scanned at baseline and after donepezil treatment. CN subjects were scanned only at baseline as a reference to identify regions correlated or anticorrelated to the hippocampus. Before each scan, participants underwent cognitive, behavioral, and functional assessments. RESULTS: After donepezil treatment, neural correlates of cognitive improvement measured by Mini-Mental State Examination scores were identified in the left parahippocampus, dorsolateral prefrontal cortex (DLPFC), and inferior frontal gyrus. Improvement in AD Assessment Scale-cognitive subscale scores correlated with the HFC changes in the left DLPFC and middle frontal gyrus. Stronger recovery in the network connectivity was associated with cognitive improvement. CONCLUSION: R-fMRI may provide novel insights into the brain's responses to AD treatment in clinical pharmacological trials, and also may predict clinical response.
Authors: Randy L Buckner; Abraham Z Snyder; Benjamin J Shannon; Gina LaRossa; Rimmon Sachs; Anthony F Fotenos; Yvette I Sheline; William E Klunk; Chester A Mathis; John C Morris; Mark A Mintun Journal: J Neurosci Date: 2005-08-24 Impact factor: 6.167
Authors: Greg Allen; Holly Barnard; Roderick McColl; Andrea L Hester; Julie A Fields; Myron F Weiner; Wendy K Ringe; Anne M Lipton; Matthew Brooker; Elizabeth McDonald; Craig D Rubin; C Munro Cullum Journal: Arch Neurol Date: 2007-10
Authors: Arash Babaei; B Douglas Ward; Robert M Siwiec; Shahryar Ahmad; Mark Kern; Andrew Nencka; Shi-Jiang Li; Reza Shaker Journal: Neuroimage Date: 2013-02-14 Impact factor: 6.556
Authors: Nina Vanessa Kraguljac; David Matthew White; Jennifer Hadley; Meredith Amanda Reid; Adrienne Carol Lahti Journal: Hippocampus Date: 2014-08-01 Impact factor: 3.899
Authors: Wenjun Li; Piero G Antuono; Chunming Xie; Gang Chen; Jennifer L Jones; B Douglas Ward; Suraj P Singh; Malgorzata B Franczak; Joseph S Goveas; Shi-Jiang Li Journal: Cortex Date: 2014-04-30 Impact factor: 4.027
Authors: Wenjun Li; Piero G Antuono; Chunming Xie; Gang Chen; Jennifer L Jones; B Douglas Ward; Malgorzata B Franczak; Joseph S Goveas; Shi-Jiang Li Journal: Neuroimage Date: 2012-01-08 Impact factor: 6.556
Authors: Judy Pa; Anne S Berry; Mariana Compagnone; Jacqueline Boccanfuso; Ian Greenhouse; Michael T Rubens; Julene K Johnson; Adam Gazzaley Journal: Ann Neurol Date: 2013-06-17 Impact factor: 10.422
Authors: Liam Zaidel; Greg Allen; C Munro Cullum; Richard W Briggs; Linda S Hynan; Myron F Weiner; Roderick McColl; Kaundinya S Gopinath; Elizabeth McDonald; Craig D Rubin Journal: J Alzheimers Dis Date: 2012 Impact factor: 4.472